TDF 300mg / 3TC 300mg / DTG 50mg, tab.
STD
DORATELD1T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
02/09/2024, 22:17:30
6.4.2.5 - Fixed-dose combinations of antiretroviral medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR27
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
TENOFOVIR (TDF) / LAMIVUDINE (3TC) / DOLUTEGRAVIR (DTG)
Therapeutic Action
Fixed-dose combination (FDC) of three antiretrovirals:
- nucleotide reverse transcriptase inhibitors (NRTI) : tenofovir (TDF) and lamivudine (3TC)
- Integrase strand transfer inhibitor (INSTI): dolutegravir (DTG)
Indications
HIV infection, according to strengths recommended by WHO
Post Exposure Prophylaxis (PEP) after accidental exposure to blood or body fluids
Instructions for use
Two different codes depending on the packaging and the indication:
- DORATELD1T-: 90-tablets packaging preferred for HIV treatment.
- DORATELD1TPEP: 30-tablets packaging reserved for PEP (Post Exposure Prophylaxis).
In children, use DTG 10mg disp. (≥ 4 weeks and ≥ 3 kg) or 50mg (≥ 20 to < 25 kg) in combination with the fixed-dose combination ABC 120mg / 3TC 60mg.
Storage
Below 25ºC